Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
Not Applicable
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Procedure: VATSProcedure: Thoracotomy
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1086
- Registration Number
- NCT03786003
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)
Phase 3
- Conditions
- Colorectal Adenocarcinoma Metastatic to the Liver
- Interventions
- Drug: TACEDrug: chemotherapy±target therapy
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2019-06-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 168
- Registration Number
- NCT03783559
- Locations
- 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
Phase 1
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 59
- Registration Number
- NCT03772353
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Phase 2
- Conditions
- Nonsmall Cell Lung CancerBrain Metastases
- Interventions
- Drug: X-396(Ensartinib) Capsule
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2018-11-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 37
- Registration Number
- NCT03753685
Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA)
Recruiting
- Conditions
- Circulating Tumor DNAColorectal CancerSurveillanceMethylation
- Interventions
- Diagnostic Test: Multigene methylation detection
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 300
- Registration Number
- NCT03737539
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas
Completed
- Conditions
- Colorectal CancerAdenoma
- Interventions
- Diagnostic Test: Next-generation sequencing (NGS)
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1138
- Registration Number
- NCT03737591
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Everolimus Related Pneumonitis in MBC
Completed
- Conditions
- PneumonitisEverolimus
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 86
- Registration Number
- NCT03730428
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
Phase 2
Recruiting
- Conditions
- Colorectal CancerRetroperitoneal Lymph Node MetastasisPara-aortic Lymph Node Metastasis
- Interventions
- Radiation: chemoradiotherapyProcedure: lymphadenectomy
- First Posted Date
- 2018-10-31
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 180
- Registration Number
- NCT03725254
- Locations
- 🇨🇳
Cancer Hospital, Fudan University, Shanghai, Shanghai, China
Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma
Completed
- Conditions
- Endometrial Adenocarcinoma
- Interventions
- Procedure: SLN mapping
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 78
- Registration Number
- NCT03716414
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
500mg Fulvestrant in HR+ MBC
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT03708432
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath